Dr. Jie Chai 柴杰
Chief Physician
Department of Gastric Surgery, Cancer Hospital of Shandong First Medical University (Shandong Cancer Hospital), Jinan
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Comprehensive treatment of gastrointestinal tumors and laparoscopic minimally invasive surgery, with specific expertise in managing complex gastrointestinal tumor cases.
Dr. Chai holds a PhD in Clinical Medicine and completed postdoctoral training at Tianjin Medical University. A visiting scholar at George Washington University (2017–2018), Dr. Chai has published over 10 SCI papers and holds 4 national invention patents. Career milestones include work at Shandong Cancer Hospital’s Gastrointestinal Surgery Department (2006–2011) and degrees from Shandong University.
Professional roles
- Youth Committee Member, General Surgery Branch, Shandong Medical Association
- Member, Anorectal Disease Branch, Shandong Medical Association
- Member, Hepatobiliary Group, General Surgery Branch, Shandong Medical Association
- Member, Gastrointestinal Tumor Surgery Branch, Shandong Anti-Cancer Association
Name order: in Chinese the family name comes first (Chai Jie). Papers usually list the name as Jie Chai or Chai J.
Selected publications
55 papers on PubMed matched by name and affiliation; 19 as first or senior author since 2016. Most recent first- or senior-author papers:
- Clin Transl Med, 2026 (senior author): Efficacy and safety of disitamab vedotin (RC48) combined with camrelizumab and S-1 for neoadjuvant therapy of locally advanced gastric cancer with HER2-overexpressing: Preliminary results of a prospective, single-arm, phase II study. PubMed 42087741
- Neoplasia, 2025 (senior author): Regulatory mechanisms of the Hippo/YAP axis by G-protein coupled estrogen receptor in gastric signet-ring cell carcinoma. PubMed 40554953
- J Am Soc Mass Spectrom, 2025 (senior author): Key Lipid Reprogramming Revealed in Gastric Signet Ring Cell Carcinoma by Spatial Mass Spectrometry Metabolomics. PubMed 40600435
- Mol Cancer Res, 2025 (senior author): METTL3 Promotes Gastric Cancer Progression via Modulation of FNTA-Mediated KRAS/ERK Signaling Activation. PubMed 40353746
- Front Oncol, 2025 (senior author): Breast cancer with gastric metastasis in invasive lobular carcinoma: a case report and literature review. PubMed 40777117
- FEBS J, 2025 (senior author): Oxaliplatin accelerates immunogenic cell death by activating the cGAS/STING/TBK1/IRF5 pathway in gastric cancer. PubMed 40260556
- Heliyon, 2024 (senior author): Integrated gene-metabolite association network analysis reveals key metabolic pathways in gastric adenocarcinoma. PubMed 39319160
- Exp Gerontol, 2024 (senior author): Study on correlation between perioperative cognitive function and nutritional status in elderly patients with gastric cancer. PubMed 38797287
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that the papers match this doctor's specialty; this check is automatic.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion